Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-25 4:36 pm Purchase | 2024-03-19 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,749,015 5.500% | 736,732 (+14.70%) | Filing History |
| 2024-03-07 4:25 pm Purchase | 2024-02-26 | 13G | TPG Inc. TPG | Integrated Core Strategies (US) LLC | 3,361,369 3.600% | 3,361,369 (New Position) | Filing History |
| 2024-02-15 4:17 pm Purchase | 2024-02-09 | 13G | Helix Acquisition Corp. II HLXB | Integrated Core Strategies (US) LLC | 1,100,000 5.800% | 1,100,000 (New Position) | Filing History |
| 2024-02-14 4:08 pm Sale | 2023-12-31 | 13G | Plum Acquisition Corp. III PLMJ | Integrated Core Strategies (US) LLC | 1,324,566 8.500% | -1,150,434 (-46.48%) | Filing History |
| 2024-02-12 4:35 pm Purchase | 2023-12-31 | 13G | United Homes Group, Inc. UHG | Integrated Core Strategies (US) LLC | 208,963 1.800% | 208,963 (New Position) | Filing History |
| 2024-02-12 4:24 pm Sale | 2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | Integrated Core Strategies (US) LLC | 0 0.000% | -5,555,085 (Position Closed) | Filing History |
| 2024-02-09 4:11 pm Purchase | 2024-01-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Integrated Core Strategies (US) LLC | 419,707 4.100% | 419,707 (New Position) | Filing History |
| 2024-02-08 4:43 pm Purchase | 2023-12-31 | 13G | Vapotherm, Inc. VAPO | Integrated Core Strategies (US) LLC | 490,044 7.800% | 490,044 (New Position) | Filing History |
| 2024-02-08 4:36 pm Purchase | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | Integrated Core Strategies (US) LLC | 108,486 0.300% | 108,486 (New Position) | Filing History |
| 2024-02-06 4:20 pm Sale | 2023-12-31 | 13G | CUTERA INC CUTRQ | Integrated Core Strategies (US) LLC | 827,032 4.100% | -663,040 (-44.50%) | Filing History |
| 2024-02-05 4:32 pm Purchase | 2023-12-31 | 13G | flyExclusive, Inc. FLYX | Integrated Core Strategies (US) LLC | 37,500 0.200% | 37,500 (New Position) | Filing History |
| 2024-02-05 4:27 pm Purchase | 2023-12-31 | 13G | LONGEVITY HEALTH HOLDINGS, INC XAGE | Integrated Core Strategies (US) LLC | 235,414 1.000% | 235,414 (New Position) | Filing History |
| 2024-02-01 4:25 pm Sale | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,012,283 4.800% | -758,611 (-13.15%) | Filing History |
| 2024-01-31 4:32 pm Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Integrated Core Strategies (US) LLC | 2,990,279 7.100% | 1,592,897 (+113.99%) | Filing History |
| 2024-01-30 4:25 pm Sale | 2023-12-31 | 13G | TKB Critical Technologies 1 USCT | Integrated Core Strategies (US) LLC | 0 0.000% | -992,538 (Position Closed) | Filing History |
| 2024-01-29 4:42 pm Sale | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 1,730,889 5.200% | -464,140 (-21.15%) | Filing History |
| 2024-01-29 4:36 pm Sale | 2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Integrated Core Strategies (US) LLC | 132,674 4.900% | -1,029 (-0.77%) | Filing History |
| 2024-01-26 4:19 pm Sale | 2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Integrated Core Strategies (US) LLC | 6,610 0.000% | -981,102 (-99.33%) | Filing History |
| 2024-01-25 4:09 pm Purchase | 2024-01-18 | 13G | Terns Pharmaceuticals, Inc. TERN | Integrated Core Strategies (US) LLC | 3,479,630 5.600% | 3,479,630 (New Position) | Filing History |
| 2024-01-24 4:16 pm Sale | 2023-12-31 | 13G | BioLife Solutions, Inc. BLFS | Integrated Core Strategies (US) LLC | 2,412,650 5.400% | -69,296 (-2.79%) | Filing History |